Natus Medical (BABY) fell after warning its Q2 revenue slipped late in the quarter due to weakness in int'l markets. The maker of medical devices for newborn care now expects $81 mil-$82 mil in sales vs. its prior outlook of $86 mil-$90 mil. Analysts saw $88.8 mil. Shares sank 13% to 12.40.
- Information Technology